Add-on Acquisition • Medical Products

Apgar Acquires DYSIS Medical

On February 4, 2025, Apgar acquired medical products company DYSIS Medical from Stage Capital

Acquisition Context
  • This is Apgar’s 1st transaction in the Medical Products sector.
  • This is Apgar’s 1st transaction in the United Kingdom.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free


M&A Deal Summary

Date February 4, 2025
Target DYSIS Medical
Sector Medical Products
Buyer(s) Apgar
Sellers(s) Stage Capital
Deal Type Add-on Acquisition

Target Company

DYSIS Medical

Edinburgh, United Kingdom
DYSIS Medical designs, develops, manufactures, and markets imaging systems for the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. DYSIS Medical was founded in 2002 and is based in Edinburgh, United Kingdom.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Apgar

Brondby, Denmark

Category Company
Founded 1991
Sector Medical Products
DESCRIPTION

Apgar is a distributor of medical-device products focused on surgical, gynaecological, radiological, and obstetric instruments and consumables, as well as patient-monitoring systems. The Company represents specialist suppliers of biopsy needles, endoscopy instruments, insufflation devices, CTG strips, and other hospital-grade medical tools. Apgar was founded in 1991 and is based in Brondby, Denmark.


Deal Context for Buyer #
Overall 1 of 1
Sector: Medical Products 1 of 1
Type: Add-on Acquisition 1 of 1
Country: United Kingdom 1 of 1
Year: 2025 1 of 1

Seller Profile 1

SELLER

Stage Capital

London, United Kingdom

Investor Investor Investor Investor


Category Private Equity Firm
Founded 2000
PE ASSETS 900M EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Stage Capital is a private equity firm that seeks investments in middle-market businesses operating in traditional industries serving as the 'backbone' of the economy. The Firm focuses its investment activity across the UK and Europe and looks for opportunities valued between €10 and €15 million where Stage Capital can invest €5 to €25 million. Stage Capital will not invest in start-ups or early stage companies. Stage Capital was formed in 2000 and is based in London with additional offices in Paris and Istanbul.


Deal Context for Seller #
Overall 23 of 23
Sector: Medical Products 2 of 2
Type: Add-on Acquisition 9 of 9
Country: United Kingdom 13 of 13
Year: 2025 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-09-26 Centrum Galardia

Starachowice, Poland

Centrum Galardia is a shopping center within a radius of 50 km from Starachowice. On an area of ​​approximately 18,000 m2, there are nearly 40 shops and service points of well-known global brands. Centrum Galardia is based in Starachowice, Poland.

Sell -